COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,050 Articles (22,627 medRxiv, 8,423 bioRxiv)

Most recent first Previous |  Page 1108: Articles 11071-11080  | Next

Repeat Subcutaneous Administration of REGEN-COV(R) in Adults is Well-Tolerated and Prevents the Occurrence of COVID-19
Isa, F., Forleo-Neto, E., Meyer, J., Zheng, W., Rasmussen, S., Armas, D., Oshita, M., Brinson, C., Folkerth, S., Faria, L., Heirman, I., Sarkar, N., Musser, B. J., Bansal, S., O'Brien, M. P., Turner, K. C., Ganguly, S., Mahmood, A., Dupljak, A., Hooper, A. T., Hamilton, J. D., Kim, Y., Kowal, B., Soo, Y., Geba, G. P., Lipsich, L., Braunstein, N., Yancopoulos, G. D., Weinreich, D., Herman, G. A., the COVID-19 Multi-dose Trial Team
10.1101/2021.11.10.21265889 — Posted: 2021-11-16 Discussion: Onsite
Presence of SARS-CoV-2 in food surfaces and public space surfaces in 3 districts of Lima, Peru.
Alvis, K., Bazan, Y. A., Maldonado, O. E., Delgado, D. F., Rodriguez, M. P., Achuy, E. G., Calvo, H. M., Mamani, P. H., Espino, L. H., Balboa, J. P. A.
10.1101/2021.11.15.21265879 — Posted: 2021-11-16
Using the Health Belief Model to design a questionnaire aimed at measuring people's perceptions regarding COVID-19 immunity certificates
Niculaescu, C. E., Sassoon, I. K., Landa-Avila, I. C., Colak, O., Jun, G. T., Balatsoukas, P.
10.1101/2021.11.12.21266257 — Posted: 2021-11-15
Individual factors influencing public's perceptions about the importance of COVID-19 immunity certificates: a cross-sectional online questionnaire survey in the UK
Niculaescu, C. E., Sassoon, I. K., Landa-Avila, I. C., Colak, O., Jun, G. T., Balatsoukas, P.
10.1101/2021.11.12.21266256 — Posted: 2021-11-15
Safety and Immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme.
Toledo-Romani, M. E., Verdecia Sanchez, L., Rodriguez Gonzalez, M., Rodriguez Noda, L., Valenzuela Silva, C., Paredes Moreno, B., Sanchez Ramirez, B., Perez Nicado, R., Gonzalez Mugica, R., Hernandez Garcia, T., Bergado Baez, G., Pi Estopinan, F., Cruz Sui, O., Fraga Quintero, A., Garcia Montero, M., Palenzuela Diaz, A., Baro Roman, G., Mendoza Hernandez, I., Fernandez Castillo, S., Climent Ruiz, Y., Santana Mederos, D., Ramirez Gonzalez, U., Garcia Vega, Y., Perez Masson, B., Wu Chen, G., Boggiano Ayo, T., Ojito Magaz, E., G. Rivera, D., Valdes Balbin, Y., Garcia Rivera, D., Verez Bencomo, v., SOBERANA Research Group
10.1101/2021.11.14.21266309 — Posted: 2021-11-15
Inactivated virus vaccine BBV152/Covaxin elicits robust cellular immune memory to SARS-CoV-2 and variants of concern
Vikkurthi, R., Ansari, A., Pai, A. R., Jha, S. N., Sachan, S., Pandit, S., Nikam, B., Kalia, A., Jit, B. P., Parray, H. A., Singh, S., Kshetrapal, P., Wadhwa, N., Shrivastava, T., Coshic, P., Kumar, S., Sharma, P., Sharma, N., Taneja, J., Pandey, A. K., Sharma, A., Thiruvengadam, R., Grifoni, A., Bhatnagar, S., Weiskopf, D., Sette, A., Garg, P. K., Gupta, N.
10.1101/2021.11.14.21266294 — Posted: 2021-11-15
Higher Vaccination Rate Predicts Reduction in SARS-CoV-2 Transmission across the United States
Au, J.
10.1101/2021.11.14.21266325 — Posted: 2021-11-15
Controlling SARS-CoV-2 in schools using repetitive testing strategies
Torneri, A., Willem, L., Colizza, V., Kremer, C., Meuris, C., Darcis, G., Hens, N., Libin, P. J.
10.1101/2021.11.15.21266187 — Posted: 2021-11-15
Should We Mitigate or Suppress the Next Pandemic? Time-Horizons and Costs Shape Optimal Social Distancing Strategies
Nowak, S. A., Lima, P. N. d., Vardavas, R.
10.1101/2021.11.14.21266322 — Posted: 2021-11-15
SARS-CoV-2 Mortality Surveillance among Community Deaths brought to University Teaching Hospital Mortuary in Lusaka, Zambia, 2020
Hamukale, A., Hines, J. Z., Sinyange, N., Fwoloshi, S., Malambo, W., Sivile, S., Chanda, S., Mucheleng'anga, L. A., Kayeyi, N., Himwaze, C. M., Shibemba, A., Leigh, T., Mazaba, M. L., Kapata, N., Zulu, P., Zyambo, K., Mupeta, F., Agolory, S., Mulenga, L. B., Malama, K., Kapina, M.
10.1101/2021.11.14.21266330 — Posted: 2021-11-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).